**Core Concept**
The question is testing the efficacy of various drugs against leprosy, specifically their bactericidal activity against the lepra bacillus (Mycobacterium leprae). The correct answer requires knowledge of the pharmacodynamics of leprosy treatment.

**Why the Correct Answer is Right**
Rifampicin is the fastest-acting drug against lepra bacilli due to its potent bactericidal activity, which is achieved through the inhibition of RNA synthesis by targeting the beta-subunit of the RNA polymerase enzyme. This results in rapid killing of the bacteria. Rifampicin's fast action is crucial in reducing the bacterial load and preventing the spread of the disease.

**Why Each Wrong Option is Incorrect**
**Option A:** Clofazimine is an anti-leprosy agent that primarily works through its anti-inflammatory and antimicrobial properties, but it is not the fastest-acting drug against lepra bacilli.

**Option B:** Dapsone is a sulfone antibiotic that is effective against leprosy, but its bacteriostatic action is slower compared to rifampicin.

**Option C:** Ofloxacin is a fluoroquinolone antibiotic that has some activity against lepra bacilli, but it is not as potent or fast-acting as rifampicin.

**Clinical Pearl / High-Yield Fact**
Rifampicin is a key component of the World Health Organization's recommended multidrug therapy regimen for leprosy, which also includes dapsone and clofazimine. The combination of these drugs is crucial in achieving a cure and preventing drug resistance.

**Correct Answer:** C.